By Jonathan Faison, SeekingAlpha
Shares of bluebird bio (NASDAQ:BLUE) have more than doubled since my initial February piece stating shares were set to fly higher, and have risen by around 50% since my August update.
BLUE data by YCharts
Previously mentioned keys to the bullish thesis included the following:
READ FULL ARTICLE HERE
Join more than 20,000 subscribers and sign up to get daily updates with Baltimore's latest business news
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
© Copyright 2017 citybizlist | Created by Mission and Powered by A4Amazing